Breaking News

NEW YORK, Nov 21 – In a coup for Informax, leading bioinformaticist Stephen Lincoln has resigned from Incyte Genomics as vice president of bioinformatics research and development to take a job with the Rockville, Md.-based company, Informax CEO Alex Titomirov said Tuesday. “He will be dev

NEW YORK, Nov 21 –In their first successful joint commercial venture, Incyte and SGI have jointly installed a Linux-based bioinformatics systems at Bristol-Myers Squibb, SGI

NEW YORK, Nov. 21 - Celera announced Tuesday that the Hospital for Sick Children in Toronto, one of Canada’s major medical research centers, had signed up for a multi-year subscription to some of its database products.

NEW YORK, Nov. 21, 2000 – Pyrosequencing of Uppsala, Sweden announced Tuesday it had sold its PSQ 96 DNA sequencing system to the Harvard Center for Cancer Prevention.

NEW YORK, Nov 21 – Structural Bioinformatics of San Diego said Tuesday it had licensed its SBdBase database of 3-dimensional protein structures to De Novo Pharmaceuticals.

NEW YORK, Nov 20 – Meltec, a new German proteomics company whose robotic system allows researchers to perform high-resolution analysis of the location of cell proteins, announced Monday that it has completed its initial round of seed financing with 38 million German marks ($16 million).

NEW YORK, Nov 20 - As Western genomics companies expand their market reach, they are increasingly looking east for market opportunities.

NEW YORK, Nov 20 – Applied Biosystems unveiled a new higher-throughput ABI Prism 7900 HT sequence detection system Monday, and says it plans to ship the system to customers during this quarter.

NEW YORK, Nov 17 – Aurora Biosciences has acquired Panvera, a

NEW YORK, Nov 17 – Applied Biosystems said Friday it has obtained the exclusive license from the University of Washington to manufacture and commercialize the isotope coded affinity tagging reagents. Applied Biosystems expects to start selling its first ICAT product in the firs

NEW YORK, Nov 17 – Informax has licensed Genomax to the Whitehead Institute under an agreement wherein Whitehead scientists will j

NEW York, Nov. 16 – Lexicon Genetics has sublicensed aspects of its proprietary knockout mouse technology to Eli Lilly, the company announced Thursday.

This story has been updated from a previous version. ROCKVILLE, Md, Nov 16 - Scott Patterson said T

ROCKVILLE, Md, Nov 16 – Publication of the public and private versions of the sequenced human genome will occur early next year, Richard Mural, senior staff scientist at Celera Genomics, said Thursday. Mural told GenomeWeb that he expects Celera to

MACCABIM, Israel, Nov 16 – Israeli start-up Glycominds has developed a new platform for the systematic study of glycans, complex carbohydrates that bind with proteins and lipids to determ

ROCKVILLE, Md, Nov 16 - Michael Waterman, considered by many to be the father of computational biology, will begin working with Celera Genomics as the company’s first fellow. Speaking Thursday at an event honoring his appointment, Waterman said he would likely work on SNPs as w

This story has been updated from a previous version. NEW YORK, Nov 16 –

NEW YORK, Nov 16 – Amersham Pharmacia Biotech said Thursday it has sold a Sniper SNP analysis system to the University of Washington under an early access agreement.

NEW YORK, Nov 15 – Roche Bioscience said Wednesday it had validated a mouse genotyping tool that could help to speed the development of new genomics-based diagnostic tools and treatments.

NEW YORK, Nov 15 - Paradigm Genetics and Lion Bioscience said Wednesday that they have entered a five-year deal to jointly develop and market a new plant and fungal metabolic profiling database.

NEW YORK, Nov 15 – Oxford Gene Technologies sued Affymetrix for patent infringement because it wants to open up the microarray market to a greater number of competitors, OGT found

NEW YORK, Nov 15 - The Monument Funds Group of Bethesda, Md., on Wednesday announced the launch of a new mutual fund that will invest in “post-sequencing” genomics companies.

NEW YORK, Nov 15 – Aclara Biosciences third-quarter revenues inched up just one percent, while costly litigation and other expenses drove losses up sharply, the company said Wednesday.  &

NEW YORK, Nov 14 – DeCode Genetics’ third quarter revenues surged 57.1 percent, pushed higher by revenues stemming from its collaboration with Roche, the population-genomics company reported Tuesday.

NEW YORK, Nov 14 – Incyte has signed a three-year agreement with Galapagos Genomics to develop and market an adenoviral gene expression platform, the companies announced Tuesday.

Pages

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.